B. Riley Has Pessimistic Outlook of TCMD Q1 Earnings

Tactile Systems Technology, Inc. (NASDAQ:TCMD) – Analysts at B. Riley decreased their Q1 2025 earnings per share estimates for Tactile Systems Technology in a research report issued on Wednesday, February 19th. B. Riley analyst K. Bauser now expects that the company will earn ($0.09) per share for the quarter, down from their prior forecast of ($0.08). B. Riley has a “Neutral” rating and a $18.00 price objective on the stock. The consensus estimate for Tactile Systems Technology’s current full-year earnings is $0.86 per share. B. Riley also issued estimates for Tactile Systems Technology’s Q2 2025 earnings at $0.22 EPS, Q3 2025 earnings at $0.19 EPS, FY2025 earnings at $0.75 EPS and FY2026 earnings at $0.81 EPS.

A number of other research analysts also recently commented on TCMD. BTIG Research downgraded Tactile Systems Technology from a “buy” rating to a “neutral” rating in a report on Tuesday, November 5th. Oppenheimer downgraded shares of Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a research note on Tuesday, November 5th. Finally, StockNews.com cut shares of Tactile Systems Technology from a “strong-buy” rating to a “buy” rating in a research note on Thursday, January 16th.

Tactile Systems Technology Trading Down 0.7 %

NASDAQ TCMD opened at $15.38 on Friday. The company has a quick ratio of 3.80, a current ratio of 4.36 and a debt-to-equity ratio of 0.11. The firm has a 50 day moving average of $17.38 and a two-hundred day moving average of $15.65. The stock has a market capitalization of $362.66 million, a PE ratio of 21.97 and a beta of 1.20. Tactile Systems Technology has a 52 week low of $11.12 and a 52 week high of $21.10.

Tactile Systems Technology (NASDAQ:TCMD) last announced its quarterly earnings data on Tuesday, February 18th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.09. The business had revenue of $85.59 million for the quarter, compared to analysts’ expectations of $85.39 million. Tactile Systems Technology had a return on equity of 9.37% and a net margin of 5.79%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in TCMD. Mackenzie Financial Corp raised its stake in shares of Tactile Systems Technology by 164.1% during the 4th quarter. Mackenzie Financial Corp now owns 36,295 shares of the company’s stock worth $622,000 after buying an additional 22,551 shares during the last quarter. PharVision Advisers LLC purchased a new stake in Tactile Systems Technology in the 4th quarter worth approximately $306,000. Virtus Fund Advisers LLC increased its stake in Tactile Systems Technology by 142.0% in the fourth quarter. Virtus Fund Advisers LLC now owns 4,199 shares of the company’s stock valued at $72,000 after purchasing an additional 2,464 shares during the last quarter. Virtus Investment Advisers Inc. lifted its holdings in shares of Tactile Systems Technology by 74.6% during the 4th quarter. Virtus Investment Advisers Inc. now owns 27,931 shares of the company’s stock worth $478,000 after acquiring an additional 11,930 shares during the period. Finally, Squarepoint Ops LLC purchased a new position in Tactile Systems Technology during the fourth quarter worth approximately $239,000. 83.43% of the stock is currently owned by institutional investors and hedge funds.

About Tactile Systems Technology

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.